|
TP1040 |
Calcitonin (salmon)
|
Calcitonin salmon,Salmon calcitonin |
CGRP Receptor
|
|
Calcitonin (salmon), a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause. |
|
TP1040L |
Calcitonin（salmon） Acetate(47931-85-1(free base))
|
Salmon calcitonin |
CGRP Receptor
|
|
Calcitonin(salmon)Acetate(47931-85-1(free base))(Salmon calcitonin) , a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause. |
|
TP1028L |
Calcitonin eel acetate
|
Calcitonin eel acetate (57014-02-5 Free base),Thyrocalcitonin eel |
Others
|
|
Calcitonin eel acetate (Calcitonin eel acetate (57014-02-5 Free base)) is the regulation of calcium homeostasis thyroid hormone peptide. |
|
TP2055 |
Calcitonin (human)
|
|
|
|
Endogenous calcitonin receptor agonist. Lowers systemic blood calcium levels and inhibits bone resorption. |
|
T37413 |
Calcitonin (salmon) (trifluoroacetate salt)
|
|
|
|
Calcitonin is a peptide hormone that lowers blood calcium level and inhibits bone resorption. It belongs to the calcitonin family of peptides, which also includes amylin , calcitonin gene-related peptide , and adrenomedu... |
|
TP1028 |
Calcitonin, eel
|
Thyrocalcitonin eel |
|
|
Calcitonin, eel is a peptide hormone that plays a crucial role in maintaining calcium balance within the body. It is extensively utilized in the scientific investigation of postmenopausal osteoporosis, a condition charac... |
|
TP1027 |
Calcitonin, eel TFA (57014-02-5 free base)
|
Thyrocalcitonin eel (TFA),Calcitonin, eel TFA |
|
|
Calcitonin,eel TFA is a thyroid hormone polypeptide that can regulate calcium homeostasis and is widely used in the study of postmenopausal osteoporosis. |
|
T78372 |
Calcitonin, eel TFA
|
Thyrocalcitonin eel TFA |
|
|
Calcitonin (eel TFA) is a thyroid hormone peptide that plays a role in regulating calcium homeostasis and is commonly utilized in the study of postmenopausal osteoporosis [1]. |
|
TP1200 |
CGRP (83-119), rat TFA
|
Calcitonin Gene Related Peptide(83-119), rat TFA |
Others
|
|
CGRP (83-119), rat TFA (Calcitonin Gene Related Peptide(83-119), rat TFA) is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. |
|
TP1677 |
Calcitonin (8-32), salmon
|
|
|
|
Calcitonin (8-32), salmon is a highly selective amylin receptor antagonist.Calcitonin is a hormone known to participate in calcium and phosphorus metabolism. In mammals, the major source of calcitonin is from the parafol... |
|
TP1202 |
Calcitonin Gene Related Peptide (CGRP) II, rat
|
CGRP II, rat |
|
|
Calcitonin Gene Related Peptide II is a potent, long-lasting vasodilator; activation of CGRP receptors on pancreatic β-cells increases plasma levels of pancreatic enzymes. |
|
T76032 |
Calcitonin Gene Related Peptide (CGRP) II, rat TFA
|
|
|
|
Calcitonin Gene-Related Peptide (CGRP) II, rat TFA, functions as a potent and enduring vasodilator by activating CGRP receptors. This compound is utilized in cardiovascular disease research [1]. |
|
T76363 |
[Tyr22] Calcitonin Gene Related Peptide, (22-37), rat
|
|
|
|
[Tyr22] Calcitonin Gene Related Peptide (22-37), rat, refers to a fragment (amino acids 22-37) of the rat calcitonin gene-related peptide (CGRP) that targets the CGRP receptor and adenylate cyclase. While calcitonin is p... |
|
TP1203 |
CGRP(83-119), rat
|
Calcitonin Gene Related Peptide (CGRP) (83-119), rat |
|
|
Calcitonin Gene Related Peptide (CGRP) (83-119), rat is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. |
|
T17194 |
Ubrogepant
|
MK-1602 |
CGRP Receptor
|
|
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies. |
|
TP1201 |
CGRP II, rat (TFA) (99889-63-1 free base)
|
Calcitonin Gene Related Peptide (CGRP) II, rat (TFA),CGRP II, rat (TFA) |
|
|
Calcitonin Gene Related Peptide (CGRP) II, rat (TFA) is a neuropeptide with 37 amino acid. |
|
T12293L |
Olcegepant
|
BIBN-4096,BIBN 4096BS |
CGRP Receptor
|
|
Olcegepant (BIBN-4096) is an effective and selective non-peptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP). |
|
T4610 |
Rimegepant
|
BMS 927711,BMS-927711,BMS927711,BHV-3000 |
CGRP Receptor
|
|
Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM. |
|
T8682 |
Vazegepant hydrochloride
|
Vazegepant HCl |
CGRP Receptor
|
|
Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study. |
|
T6590 |
MK-3207 Hydrochloride
|
MK-3207 HCl |
CGRP Receptor
|
|
MK-3207 Hydrochloride (MK-3207 HCl) is a potent CGRP receptor antagonist with IC50 and Kiof 0.12 nM and 0.022 nM, highly selective versus human AM1, AM2, CTR, and AMY3. Phase 2. |
|
TP2233L |
CGRP (rat) acetate
|
|
Others
|
|
CGRP (rat) acetate is a calcitonin gene-related peptide (CGRP). CGRP (rat) acetate is a potent vasodilator. |
|
TP1134L |
HCGRP-(8-37) acetate
|
HCGRP-(8-37) acetate (119911-68-1 free base) |
CGRP Receptor
|
|
HCGRP-(8-37) acetate is a human calcitonin gene-related peptide (hCGRP) fragment acetate and also an antagonist of CGRP receptor. |
|
T76874 |
Erenumab
|
AMG-334 |
CGRP Receptor
|
|
Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks. |
|
TP1257L |
Adrenomedullin (AM) (22-52), human acetate
|
Adrenomedullin (AM) (22-52), human acetate（159899-65-7 Free base） |
CGRP Receptor
|
|
|
|
T76682 |
Galcanezumab
|
LY 2951742 |
CGRP Receptor
|
|
Galcanezumab is a humanized IgG4 monoclonal antibody targeting the CGRP ligand, which binds to the ligand calcitonin gene-related peptide. Galcanezumab can be used to prevent and treat migraines or cluster headaches. |
|
T23406 |
SUN B8155
|
SUN-B 8155 |
Others
|
|
calcitonin (CT) receptor agonist |
|
T26682 |
Atogepant
|
MK 8031,MK8031. Atogepant,MK-8031 |
|
|
Atogepant is an antagonist of calcitonin gene-related peptide receptor. |
|
TP2044 |
α-CGRP(human)
|
α-CGRP (human) |
|
|
Endogenous calcitonin gene-related peptide receptor (CGRP) agonist. |
|
T39522 |
HTL22562
|
|
|
|
HTL22562 is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine. |
|
T16093 |
Telcagepant
|
MK-0974 |
Others
|
|
|
|
T70248 |
4991W93
|
|
|
|
4991W93 is a 5HT(1B/1D) receptor partial agonist, inhibiting electrically induced plasma extravasation, blocking neurogenic plasma protein extravasation, inhibiting release of calcitonin gene-related peptide. |
|
TP1131 |
β-CGRP, human TFA (101462-82-2 free base)
|
CGRP-II (Human) (TFA),Human β-CGRP (TFA),β-CGRP, human TFA |
|
|
β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and... |
|
T71246 |
DD04107
|
|
|
|
DD04107 is a novel inhibitor of α-calcitonin gene-related peptide (α-CGRP) exocytotic release from primary sensory neurons, selectively interacting with Synaptotagmin 1. |
|
T26796 |
BI-44370
|
|
|
|
BI-44370, a CGRP (calcitonin gene-related peptide) receptor antagonist, can be used to treat migraines and other chronic pain. |
|
T12293 |
Olcegepant hydrochloride
|
BIBN-4096 hydrochloride,BIBN4096BS hydrochloride |
Others
|
|
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP). |
|
TP2049 |
CRSP-1
|
|
|
|
Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related pepti... |
|
T27025 |
Cizolirtine citrate
|
E-4018,E4018,E 4018 |
|
|
Cizolirtine is a calcitonin gene-related peptide antagonist. Cizolirtine may be useful for alleviating some neuropathic somatosensory disorders, in particular cold allodynia, with a reduced risk of undesirable side effec... |
|
T75978 |
β-CGRP, human TFA
|
|
|
|
Human β-CGRP TFA (β-CGRP, human TFA) is a calcitonin peptide that functions through interaction with the calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP) complex, demonstrating IC50... |
|
TP1625 |
Adrenomedullin (11-50), rat
|
|
|
|
Adrenomedullin 11-50 rat is a peptide fragment of adrenomedullin that possesses systemic vasodilator activity at the level of calcitonin gene-related peptide-1 (CGRP1) receptor activation. Adrenomedullin and its peptide ... |
|
T73703 |
(3R,5R,6S)-Atogepant
|
|
|
|
Atogepant ((3R,5R,6S)-MK-8031) is the enantiomer of itself and serves as a calcitonin gene-related peptide (CGRP) receptor antagonist, primarily utilized in migraine research. |
|
T70837 |
Rimegepant sulfate hydrate
|
|
|
|
Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown ... |
|
TP1232 |
Amylin, amide, rat
|
Amylin (rat) |
|
|
Amylin is a peptide that displays 50% homology with calcitonin gene-related peptide (CGRP), Amylin is colocalized with somatostatin in endocrine cells of the gastric fundus. In isolated mouse stomach, amylin caused a con... |
|
TP1130 |
β-CGRP, human
|
CGRP-II (Human),Human β-CGRP |
|
|
β-CGRP, human ,a 37-amino acid peptide,is the beta form of Calcitonin-gene-related peptide (β-CGRP), involved extensively in regulation of the cardiovascular and nervous systems. β-CGRP contains a disulphide bridge at th... |
|
TP1183 |
Amylin, amide, human
|
DAP amide, human |
|
|
Amylin, a 37-amino acid polypeptide that is structurally related to calcitonin, is secreted from the B cells of the pancreas. Amylin has anoretic effects in rats. Amylin may be responsible for the etiology of insulin res... |
|
TP1954 |
PHM-27 (human)
|
|
|
|
Endogenous peptide product of human prepro-VIP and analog of porcine PHI-27; potent agonist for the human calcitonin receptor (EC50 = 11 nM). Transgenic mice expressing the human VIP/PHM 27 gene in pancreatic β-islets di... |
|
T76678 |
Eptinezumab
|
|
|
|
Eptinezumab, a human monoclonal antibody, specifically binds to and blocks the calcitonin gene-related peptide (CGRP) from binding to its receptor, thus acting as a preventive treatment for migraine in adults [1]. |
|
T76262 |
Cagrilintide
|
|
|
|
Cagrilintide, an investigational novel long-acting acylated amylin analogue, functions as an agonist for nonselective amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). It significantly reduces ... |
|
T76680 |
Fremanezumab
|
|
|
|
Fremanezumab (TEV-48125), a humanized IgG2a monoclonal antibody, potently and selectively targets the calcitonin gene-related peptide (CGRP), a 37-amino acid neuropeptide implicated in the central and peripheral mechanis... |
|
T75934 |
AC 187 TFA
|
|
|
|
AC 187 TFA, a potent and orally active amylin receptor antagonist, exhibits an IC50 of 0.48 nM and a Ki of 0.275 nM. It demonstrates greater selectivity for the amylin receptor over calcitonin and CGRP receptors and has ... |
|
T36555 |
Tyr-α-CGRP (human) (trifluoroacetate salt)
|
|
|
|
Tyr-α-CGRP is an N-terminal extended tyrosinated analogue of α-calcitonin gene-related peptide . It binds to amylin receptors AMY1 and AMY3 in COS-7 cells expressing the human receptors (IC50s = 141 and 1.86 nM, respecti... |
